Mainz Biomed N.V.
MYNZ
$3.07
-$0.15-4.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 12/31/2023 | 06/30/2023 | 03/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -5.31M | -5.31M | -5.18M | -8.25M | -40.00K |
| Total Depreciation and Amortization | 260.00K | 260.00K | 204.50K | 171.00K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 885.40K | 885.40K | 88.60K | 1.18M | -- |
| Change in Net Operating Assets | -304.60K | -304.60K | 235.10K | 1.78M | 40.00K |
| Cash from Operations | -4.47M | -4.47M | -4.66M | -5.12M | 0.00 |
| Capital Expenditure | 7.90K | 7.90K | -161.80K | -123.60K | -- |
| Sale of Property, Plant, and Equipment | 11.70K | 11.70K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 16.40K | 16.40K | -- | -- | -- |
| Other Investing Activities | 75.00K | 75.00K | -100.00K | 0.00 | -- |
| Cash from Investing | 110.90K | 110.90K | -261.80K | -123.60K | -- |
| Total Debt Issued | 670.00K | 670.00K | 0.00 | 5.06M | -- |
| Total Debt Repaid | -270.60K | -270.60K | -1.03M | -252.30K | -- |
| Issuance of Common Stock | 6.62M | 6.62M | 4.50M | 611.40K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.02M | 7.02M | 3.47M | 5.42M | -- |
| Foreign Exchange rate Adjustments | -33.50K | -33.50K | -798.30K | -123.80K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.63M | 2.63M | -2.25M | 52.90K | -- |